are any glp 1 approved for weight loss Rx Trends: Real-World Data on GLP-1s What to Make of the

Dual agonism with GLP-1 and amylin As WL with GLP-1 RA and amylin analogues results both from distinct and overlapping pathways, a combination of these entero-pancreatic hormones may induce a synergistic WL effect [84]

Weight loss often improves these markers, so baseline measurements help track progress and cardiovascular benefits

Oral semaglutide (Rybelsus) already exists for diabetes, with daily doses of 3, 7, or 14 mg compared to the weekly injectable range of 0.25-2.4 mg

By understanding your genetic predispositions alongside your current metabolic status, you and your provider can make a more evidence-informed decision about which GLP-1 option to begin with, expected timelines for dose optimization, and whether compounded semaglutide, tirzepatide, or dual-agonist protocols may best support your health goals

He noted that while the study was relatively short term, the effect was clear and said the once-daily pill could be particularly attractive as an option for people living with diabetes not wanting injectable therapy